Erratum to: Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies

On page 837 of the article by Woolston et al.,¹ in the sentence reproduced below, “ibrutinib” should be replaced with “acalabrutinib”:

Incorrect sentence:

“Sample R002-A was collected after 3 months of combination therapy with ibrutinib and venetoclax.”

Correct sentence:

“Sample R002-A was collected after 3 months of combination therapy with acalabrutinib and venetoclax.”

Footnotes

• Received January 25, 2024
• Accepted January 25, 2024

Correspondence

^*DWW, NDL, and MS contributed equally as first authors.

^#IB, RAR, and CCSY contributed equally as senior authors

C.S. Yeung_Cecilia cyeung@fredhutch.org